- The following report previously appeared in CATIE News. We are putting it in this issue of TreatmentUpdate to underscore some of the issues related to care and ...
- In TreatmentUpdate 215 we published a short guide about some classes of treatment for hepatitis C virus (HCV). Before reading the rest of the reports in this ...
- Reports from China, Italy and the U.S. suggest that some people with underlying cardiovascular disease are at heightened risk for severe illness associated with ...
- Historically, scientists have thought that coronaviruses generally caused infection of the respiratory tract in people (the wet tissues of the nose, mouth, ...
- Research on COVID-19 and the virus that causes it - SARS-CoV-2 - is still in its infancy. As a result, study designs on COVID-19 have not been ideal and any ...
- As the COVID-19 pandemic began sweeping around the world, many clinical trials were initiated to test drugs that were already approved for one condition ...
- Remdesivir (GS-5734) was originally developed for the potential treatment of Ebola virus infection. However, in clinical trials it was not as effective as other ...
- Researchers in North America, Europe and Asia conducted a randomized, placebo-controlled study of remdesivir in adults hospitalized with COVID-19. Analysis ...